Afaq Motiwala

Afaq Motiwala practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Afaq Motiwala's NPI, 1205185345, was assigned on September 5, 2012. Afaq Motiwala graduated from Aga Khan Medical College in 2009. Afaq Motiwala holds Texas license S6458.

Afaq Motiwala's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Afaq Motiwala's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Afaq Motiwala to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Afaq Motiwala practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Afaq Motiwala's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Afaq Motiwala is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Afaq Motiwala's licenses on file in 3 states: Texas, Illinois and Pennsylvania.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Afaq Motiwala treats.

CMS data shows 799 Medicare services from Afaq Motiwala across 14 procedure codes in 2024, for 579 Medicare patients. Medicare paid $34,300 for them.

CMS counts 579 Medicare patients who saw Afaq Motiwala in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Afaq Motiwala's median patient age at 72, with 50% women.

In 2024, Afaq Motiwala wrote 508 Medicare Part D claims for 107 patients. 84% of them were for generic drugs. CMS names the drug for 427 of them, across 14 drugs with 11 or more claims each, at $45,711 in total drug cost. In 2023, CMS named 407 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Afaq Motiwala for performance year 2024, reported as part of a group. Afaq Motiwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of coronary angioplasty and stenting by Afaq Motiwala, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Afaq Motiwala, published from 2011 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Internship and Residency, Pakistan and Clinical Competence. Afaq Motiwala has published most often in Curr Probl Cardiol. Afaq Motiwala's most frequent co-authors are Syed Abbas Raza Gilani, MD, Wissam Ibrahim Khalife, MD and Aiham Albaeni, MD.

CMS Open Payments shows 162 general payments to Afaq Motiwala from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Abbott Laboratories paid the most, $5,135.

Afaq Motiwala graduated from Aga Khan Medical College in 2009.

Afaq Motiwala is in network with 23 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.